Google sister-company Verily is teaming with big pharma on clinical trials
“The clinical trials marketplace and vendor space hasn’t been disrupted in quite some time, said Tom Cassels, chief strategy officer for a company called Leidos, which specializes in health technology. “So the opportunity to both improve the efficacy and speed of clinical trials is attractive, and it’s a huge market.”
CMO at Verily, Jessica Mega speaks onstage during JDRF LA’s IMAGINE Gala to benefit type 1 diabetes research at The Beverly Hilton on May 14, 2016 in Beverly Hills, California. CMO at Verily, Jessica Mega speaks onstage during JDRF LA’s IMAGINE Gala to benefit type 1 diabetes research at The Beverly Hilton on May 14, 2016 in Beverly Hills, California. Todd Williamson | Getty Images Verily, the health and life sciences company under Google parent-company Alphabet , is moving into the clinical trials space. The company announced Tuesday strategic alliances with the pharmaceutical companies Novartis, Sanofi, Otsuka and Pfizer to help it move more deeply into the medical studies market. The goals for Verily, and its pharma partners, are to reach patients in new ways, make it easier to enroll and participate in trials, and aggregate data across a variety of sources, including the electronic medical record or health-tracking wearable devices. Clinical trials have historically been expensive processes that rely on outdated technologies. So pharma companies are looking to leverage the latest technologies from companies like Google to reach patients in a more targeted way and get their most promising drugs approved more quickly. That’s where Verily comes in. […]
